Skip to content

Can-Fite BioPharma Ltd.

CANF· NYSECore metricsCIK 1536196

Pharmaceutical preparations551 peers

Last sale
Nov 12, 2026 · -7.01%
Market cap
$1.91M
1.31M shares
Filings
868
$405.00K
FY 2025−39.9% FY25 yoy
-$9.83M
FY 2025N/M FY25 yoy
-$9.95M
FY 2025N/M FY25 yoy
-$8.95M
FY 2025derivedN/M FY25 yoy
-$5.97
FY 2025N/M FY25 yoy
$5.53M
FY 2025+14.6% FY25 yoy
$1.91M
—
4.7×
0.3×
-468.28%
—

FY2025 figures · derived

Price

$1.46+265.00%+$1.06past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$405.00KFY 2025
$3.82M0FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$405,000reported
FY 20242024-12-31$674,000reported
FY 20232023-12-31$743,000reported
FY 20222022-12-31$810,000reported
FY 20212021-12-31$853,000reported
FY 20202020-12-31$763,000reported
FY 20192019-12-31$2,032,000reported
FY 20182018-12-31$3,820,000reported
FY 20172017-12-31$789,000 revisedreported
FY 20162016-12-31$165,000reported

Capital returns

Dividends and buybacks · FY2020 to FY2021
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2021$2.59M—$2.59M—815.75M sh+75.9%—
FY2020$715.00K—$715.00K—463.77M sh+284.4%—

Pharmaceutical preparations

Can-Fite BioPharma Ltd. is the 231st largest of the 552 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Can-Fite BioPharma Ltd. · CIK 1536196 · Engraved from SEC EDGAR